PAREXEL International is a multinational life sciences consulting firm. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the market today. The company publishes the annual PAREXEL R&D Statistical Sourcebook, operates the PAREXEL-Academy, and councils all of the top 50 biopharmaceutical and top 30 biotechnology companies.
PAREXEL was founded in 1982 by Josef von Rickenbach and organic chemist Anne B. Sayigh initially to advise Japanese and German firms on how to navigate the FDA approval process. The firm has grown organically over the years and through 40 acquisitions. Josef von Rickenbach is credited with establishing PAREXEL’s culture and practices based on the principles he experienced as a researcher at Schering-Plough in Lucerne, Switzerland.
In 1990, the firm expanded internationally and established new practice areas. By 1999 it had a staff of 4,500 and 45 offices. In the 2000s, it grew to over 18,000 employees. PAREXEL’s consulting and clinical trial work has helped establish many household drug brands and contributed to numerous successes in modern pharmacology.
|Services||clinical trial management, data management, medical writing, biostatistics, pharmacovigilance, regulatory consulting|
|Headquarters||Waltham, Massachusetts, United States of America; 80+ facilities in 51+ countries|
|Industry||Clinical research organizations Pharmaceutical|
|Key people||Chairman and CEO: Josef H. von Rickenbach|
|Traded as||NASDAQ: PRXL S&P 400 Component|
NPS is a customer loyalty metric that measures customers’ willingness to not only return for another purchase or service but also make a recommendation to their family, friends or colleagues.
It is a powerful and effective technique, which can greatly increase a company's revenue if used properly.
The main advantages of NPS are close correlation with a company's growth and easy collection, interpretation and communication of the data.
Net Promoter Score is a number from -100 from 100.
Scores higher than 0 are typically considered to be good and scores above 50 are considered to be excellent.
The industry average for Health Care / Biotechnology: Commercial Physical & Biological Resarch is 0.
The final Net Promoter Score of a company strongly depends on a context in which the satisfaction is measured.
Consider an example: If PAREXEL International Corporation sends out NPS surveys immediately after purchase, they are tracking their customers' initial excitement and the checkout experience.
On the other hand, if they survey their customers a few weeks after the purchase they are also tracking how satisfied their customers are with their products and services over time.
Therefore, comparing the NPS score of PAREXEL International Corporation with your own without any further context is not that useful.
What is extremely useful though, is using the NPS methodology to track the satisfaction of your customers over time. That's where Customer.guru comes in.
|CIGNA||Insurance / Health and Life Insurance||-1|
|Vodafone||Telecommunications / Wireless Carrier||-1|
|Chase||Financial Services / Banking||-1|
|Cleeng||Technology / Software||1|
|Fifth Third Bank||Financial Services / Banking||1|
|Accenture Consulting||Technology / Other||1|
|Dish||Telecommunications / Cable/TV service||1|
|Morrisons||Consumer Brands / Grocery||2|
|Mediacom||Consumer Brands / Entertainment||2|
|ESPN||Consumer Brands / Entertainment||2|
We have estimated the Net Promoter Score of PAREXEL International Corporation based on the publicly available information
including the sentiment of the company-related tweets, 3rd party reviews, and Alexa ratings.